Share
Journal Information
Most cited
1
Mepolizumab for severe eosinophilic asthma – A one-year real life Portuguese studyR Brás, M Paulino, C Varandas, C Coutinho, MI Silva, R Limão, C Costa, E Alonso, ... A Mendes
Pulmonol. 2021;27:579-81
1
Open access
3
Functional status in the COVID-19 era: ALERT, ALERT, ALERT!A. Marques
Pulmonol. 2021;27:481-3
3
Open access
14
Continuous noninvasive ventilatory support outcomes for patients with neuromuscular disease: a multicenter data collaborationM.R. Gonçalves, J.R. Bach, Y. Ishikawa, L. Saporito, J.C. Winck
Pulmonol. 2021;27:509-17
14
Open access
4
High-flow oxygen therapy in palliative care: A reality in a near future?JC Duarte, O Santos, C Lousada, P Reis-Pina
Pulmonol. 2021;27:479-80
4
Open access
3
Rituximab for the treatment of acute onset Interstitial Lung Disease in primary Sjogren's syndromeGiulia Klinowski, Filippo Gozzi, Fabiana Trentacosti, Dario Andrisani, Marco Sebastiani, Enrico M. Clini
Pulmonol. 2021;27:575-8
3
Open access
37
Measures of physical performance in COVID-19 patients: a mapping reviewCarla Simonelli, Mara Paneroni, Michele Vitacca, Nicolino Ambrosino
Pulmonol. 2021;27:518-28
37
Open access
Special content about COVID-19
- Assisted mobilisation in critical patients with COVID-19
- Two years of COVID-19: Trends in rehabilitation
- Comparison of different field tests to assess the physical capacity of post-COVID-19 patients
- New insights in circulating peptidome to differentiate mild to severe COVID-19 patients: Preliminary report
Open access
This work is licensed under a Creative Commons Attribution 4.0 International License.
Publish in
Pulmonology
